Rafael Holdings, Inc. owns commercial real estate assets and interests in preclinical and clinical stage pharmaceutical companies. The company is headquartered in Newark, New Jersey. Show more

520 BROAD STREET, NEWARK, NJ, UNITED STATES, 07102, Newark, NJ, 07102, USA

https://www.rafaelholdings.com

REAL ESTATE SERVICES

REAL ESTATE

Start AI Chat

Market Cap

103.5M

52 Wk Range

$1.12 - $3.96

Previous Close

$1.99

Open

$2.04

Volume

67,183

Day Range

$1.92 - $2.04

Enterprise Value

73.59M

Cash

30.5M

Avg Qtr Burn

-7.284M

Insider Ownership

38.12%

Institutional Own.

7.33%

Qtr Updated

04/30/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Trappsol® Cyclo™ (hydroxypropyl-beta-cyclodextrin) Details Niemann-Pick Disease Type C1 (NPC1)	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CPI-613 (devimstat) + hydroxychloroquine Details Solid tumor/s, Cancer, Sarcoma	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CPI-613 (devimistat) Details Solid tumor/s, Pancreatic cancer, Cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CPI-613 (devimstat) Details Blood cancer, Cancer, Acute myeloid leukemia	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CPI-613 (devimstat) Details Blood cancer, Cancer, Leukemia, Lymphoma	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CPI-613 (devimstat) Details Solid tumor/s, Pancreatic cancer, Cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.